Elucidating microvascular contributions to cognitive impairment at single-cell resolution

点击翻译按钮获取中文摘要

Project Summary/Abstract Dementia afflicts over 55 million people worldwide. With an aging population and no effective treatments available, this number is projected to nearly triple by 2050. Cerebral small vessel disease (CSVD) causes up to 45% of all dementia, accounts for ~20% of strokes, and appears in most Alzheimer’s disease patients. CSVD arises from pathologies of the brain’s ~400 miles of oxygen and nutrient-delivering small arteries, arterioles, venules, and capillaries; and is recognized as the most important vascular contributor to cognitive impairment and dementia (VCID). CSVD pathologies, such as arteriolosclerosis and microinfarcts, develop insidiously to strangulate cerebral blood flow, compromise the blood-brain barrier, and trigger neuroinflammation. Recent developments in single-nucleus sequencing technologies have begun elucidating fundamental molecular and cellular processes underlying human neurological disease. They have revealed selectively vulnerable cell populations, transcriptional dysfunction across disease stages, and the mechanisms of genetic risk variants to inform new research areas and therapeutic targets. Yet, single-nucleus studies have mostly lost human brain vascular cells unknown reasons, leaving our understanding of CSVD lagging. To address this challenge, we invented Vessel Isolation and Nuclei Extraction for Sequencing (VINE-seq) to efficiently capture human brain vascular cell types from frozen postmortem brains for single-nucleus profiling. Here, we will combine VINE-seq with multimodal single-nucleus RNA and ATAC sequencing to generate a first ~1.9 million vascular atlas of early, mid-, and late-stage CSVD alongside age-matched cognitively normal controls. Samples come from a specially organized CSVD set of 191 postmortem midfrontal gyrus watershed tissue, prioritized via MRI and nerve tractography, from the Religious Order Study and Memory and Aging Project (ROSMAP). Samples exhibit no confounding non-vascular neurodegenerative pathology and are richly annotated with demographic, genomic, pathologic, and longitudinal cognitive data to link molecular readouts to phenotypes. Thus, we will combine VINE-seq with multimodal single-nucleus RNA- and ATAC- sequencing (snRNA/ATAC-seq) to generate a first vascular atlas of CSVD (A1); reveal the molecular signatures of CSVD progression (A2); and determine the causal mechanisms of CSVD genetic risk (A3). As vascular risk factors are modifiable, insights revealed here may be critical to understanding and ultimately treating VCID and mixed pathology dementias.